Also trades as: 0QNO.L (LSE) · $vol 53M · LZAGY (OTC) · $vol 3M · LZAGF (OTC) · $vol 0M

CHF 565.60 ($682.70)

+5.00 (+0.89%)

Weekly Expected Move ±3.3%

CHF 528 CHF 547 CHF 566 CHF 584 CHF 603

SIX · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · CHF 39.5B mcap · 70M float · 0.203% daily turnover

Revenue

$6.5B -0.7% ▼

5Y CAGR: +7.7%

Gross Profit

$2.3B +6.9% ▲

5Y CAGR: +6.2%

Operating Income

$1.4B +42.3% ▲

5Y CAGR: +7.9%

Net Income

$949M +49.2% ▲

5Y CAGR: +1.8%

EPS (Diluted)

$13.51 +51.5% ▲

5Y CAGR: +3.0%

EBITDA

$1.3B -15.0% ▼

5Y CAGR: -1.1%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$5.4B	$6.2B	$6.7B	$6.6B	$6.5B
YoY Growth	+20.0%	+15.0%	+7.9%	-2.1%	-0.7%
Cost of Revenue	$3.4B	$3.9B	$4.8B	$4.4B	$4.2B
Gross Profit	$2.0B	$2.3B	$1.9B	$2.2B	$2.3B
Gross Margin	36.4%	37.0%	29.0%	32.9%	35.4%
R&D Expenses	$90M	$95M	$105M	$0	$0
SG&A Expenses	$754M	$827M	$837M	$945M	$877M
Operating Expenses	$1.1B	$951M	$1.1B	$1.2B	$966M
Operating Income	$819M	$1.3B	$880M	$964M	$1.4B
Operating Margin	15.1%	21.7%	13.1%	14.7%	21.0%
Interest Expense	$72M	$73M	$90M	$155M	$162M
Income Before Tax	$788M	$1.4B	$790M	$754M	$1.1B
Tax Expense	$83M	$230M	$135M	$117M	$192M
Net Income	$2.9B	$1.2B	$654M	$636M	$949M
Net Margin	54.4%	19.5%	9.7%	9.7%	14.5%
EPS (Diluted)	$39.52	$16.34	$8.88	$8.92	$13.51
EBITDA	$1.4B	$2.1B	$1.5B	$1.5B	$1.3B
Shares Outstanding	74M	74M	74M	71M	70M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$3.2B	$3.1B	$3.6B	$3.1B	$3.5B	$3.6B	$3.0B	$3.4B
Cost of Revenue	$2.0B	$2.0B	$2.8B	$1.9B	$2.5B	$2.3B	$2.0B	$2.1B
Gross Profit	$1.2B	$1.1B	$840M	$1.1B	$1.0B	$1.3B	$970M	$1.3B
Gross Margin	38.3%	36.0%	23.1%	36.5%	29.7%	36.1%	32.8%	38.4%
R&D Expenses	$186M	$0	$194M	$0	$206M	$0	$0	$0
SG&A Expenses	$346M	$497M	$138M	$540M	$574M	$667M	$318M	$490M
Operating Expenses	$346M	$497M	$138M	$582M	$614M	$675M	$318M	$490M
Operating Income	$896M	$611M	$702M	$534M	$470M	$617M	$652M	$805M
Operating Margin	27.6%	19.9%	19.3%	17.5%	13.4%	17.3%	22.1%	23.9%
Interest Expense	$34M	$31M	$28M	$52M	$68M	$83M	$84M	$57M
Income Before Tax	$853M	$499M	$304M	$395M	$360M	$525M	$576M	$708M
Tax Expense	$134M	$75M	$60M	$65M	$52M	$99M	$93M	$136M
Net Income	$723M	$410M	$244M	$329M	$307M	$426M	-$701M	$591M
Net Margin	22.3%	13.3%	6.7%	10.8%	8.7%	11.9%	-23.7%	17.5%
EPS (Diluted)	$9.73	$5.52	$3.36	$4.61	$4.14	$6.07	$-10.00	$8.45
EBITDA	$1.2B	$899M	$1.0B	$824M	$764M	$1.0B	$822M	$1.1B
Shares Outstanding	74M	74M	73M	71M	74M	70M	70M	70M

LONN.SW SIX